Macrocyclic Compounds As Hcv Ns3 Protease Inhibitors

  • Published: Aug 28, 2008
  • Earliest Priority: Feb 20 2007
  • Family: 11
  • Cited Works: 0
  • Cited by: 21
  • Cites: 4
  • Additional Info: Full text
Abstract

The present application describes macrocyclic compounds of formula (I) with NS3 protease inhibitory activity for treating hepatitis C virus infection.


Claims
CPC Classifications

Download Citation


Sign in to the Lens

Feedback